These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 147689)
21. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts]. Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604 [No Abstract] [Full Text] [Related]
22. [Gold therapy of rheumatic diseases]. Berndt H Z Arztl Fortbild (Jena); 1987; 81(9):416. PubMed ID: 3114970 [No Abstract] [Full Text] [Related]
23. IV N-acetylcysteine treatment of hematologic reactions to chrysotherapy. Godfrey NF; Peter A; Simon TM; Lorber A J Rheumatol; 1982; 9(4):519-26. PubMed ID: 6813467 [TBL] [Abstract][Full Text] [Related]
24. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis. Davis P; Menard H; Thompson J; Harth M; Beaudet F J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393 [TBL] [Abstract][Full Text] [Related]
25. Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions. Klinefelter J Rheumatol; 1975 Mar; 2(1):21-7. PubMed ID: 127042 [TBL] [Abstract][Full Text] [Related]
26. Treatment with auranofin in patients with rheumatoid arthritis, previously experiencing drug related side effects to sodium aurothiomalate. Davis P; Landon M J Rheumatol; 1985 Jun; 12(3):622. PubMed ID: 3930724 [No Abstract] [Full Text] [Related]
27. Adverse immune reactions to gold in rheumatoid arthritis: lack of skin reactivity. Goldermann R; Schuppe HC; Gleichmann E; Kind P; Merk H; Rau R; Goerz G Acta Derm Venereol; 1993 Jun; 73(3):220-2. PubMed ID: 8105626 [TBL] [Abstract][Full Text] [Related]
28. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin. Tumiati B; Veneziani M; Bellelli A; Portioli I J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794 [No Abstract] [Full Text] [Related]
29. [Gold therapy in chronic polyarthritis. Differentiation of allergic and toxic side effects]. Bene E; Megyeri A; Györi J Z Rheumatol; 1980; 39(3-4):109-16. PubMed ID: 6448525 [TBL] [Abstract][Full Text] [Related]
30. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis. Kovarsky J Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276 [No Abstract] [Full Text] [Related]
31. The use of gold therapy with rheumatoid arthritis. Phillips KF Orthop Nurs; 1983; 2(4):31-4. PubMed ID: 6422427 [No Abstract] [Full Text] [Related]
32. Efficacy and toxicity of retreatment with gold salts: a retrospective review of 25 cases. Sagransky DM; Greenwald RA J Rheumatol; 1980; 7(4):474-8. PubMed ID: 6775078 [TBL] [Abstract][Full Text] [Related]
39. [Chrysotherapy and side effects (author's transl)]. Eberl R Wien Klin Wochenschr Suppl; 1974; 25():3-22. PubMed ID: 4279096 [No Abstract] [Full Text] [Related]
40. Chrysotherapy in rheumatoid arthritis with particular emphasis on the effect of chrysotherapy on radiographical changes and on the optimal time of initiation of therapy. Luukkainen R Scand J Rheumatol Suppl; 1980; 34():1-56. PubMed ID: 6791272 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]